Publicaciones en colaboración con investigadores/as de University of Oxford (11)

2021

  1. Galactosemia: Towards pharmacological chaperones

    Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-15

2019

  1. NAD(P)H quinone oxidoreductase (NQO1): An enzyme which needs just enough mobility, in just the right places

    Bioscience Reports, Vol. 39, Núm. 1

2016

  1. Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase

    Human Molecular Genetics, Vol. 25, Núm. 11, pp. 2234-2244

  2. Natural small molecules as stabilizers and activators of cancer-associated NQO1 polymorphisms

    Current Drug Targets, Vol. 17, Núm. 13, pp. 1506-1514

2013

  1. Distinct ubiquitin binding modes exhibited by SH3 domains: Molecular determinants and functional implications

    PLoS ONE, Vol. 8, Núm. 9

  2. Multimeric and differential binding of CIN85/CD2AP with two atypical proline-rich sequences from CD2 and Cbl-b

    FEBS Journal, Vol. 280, Núm. 14, pp. 3399-3415

2012

  1. Early amyloidogenic oligomerization studied through fluorescence lifetime correlation spectroscopy

    International Journal of Molecular Sciences, Vol. 13, Núm. 8, pp. 9400-9418

1998

  1. Analysis of the interactions between streptokinase domains and human plasminogen

    Protein Science, Vol. 7, Núm. 10, pp. 2190-2199

1996

  1. Molecular characterisation of a thermoactive β-1,3-glucanase from Oerskovia xanthineolytica

    Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology, Vol. 1296, Núm. 2, pp. 145-151

  2. The domain organization of streptokinase: Nuclear magnetic resonance, circular dichroism, and functional characterization of proteolytic fragments

    Protein Science, Vol. 5, Núm. 4, pp. 693-704

  3. Thermal stability of the three domains of streptokinase studied by circular dichroism and nuclear magnetic resonance

    Protein Science, Vol. 5, Núm. 12, pp. 2583-2591